ZEROKEY
1.6.2022 20:08:12 CEST | Business Wire | Press release
ZeroKey today unveiled their second-generation technology, Quantum RTLS™, the world’s most accurate large-scale 3D real-time location system (RTLS). The technology enables unprecedented operational visibility of manufacturing , supply chain, logistics , and human-centric workflows to drive real-time optimization and integration of processes across entire organizations. Quantum RTLS ™ provides hyper-accurate digitization of the location of assets for closed-loop control of highly dynamic workflows, real-time monitoring of human-centric processes, process analytics, and high-fidelity digital twinning.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220601005976/en/
To perform data-driven decision-making, businesses must be able to derive actionable information from the data they are collecting, and that is where ZeroKey’s technology excels. The true value of a connected asset is unlocked through Quantum RTLS™ location technology, enabling an organization to make better-informed and more timely decisions. Through the digitization of both time and location, ZeroKey provides the highest level of accuracy and actionable analytics through its Spatial Intelligence Platform , giving customers 4D operational intelligence that truly delivers on the promise of Industry 4.0.
“The hyper accuracy of Quantum RTLS empowers companies to solve problems that have never been solved before in industrial environments,” says Matthew Lowe, CEO & Co-founder at ZeroKey. “Production efficiency and operational visibility are exponentially increased when operations are digitized in 4D with millimeter accuracy. Our technology enables unprecedented process optimization and quality control, allowing businesses to maximize their output while reducing costly errors.”
Features and benefits of Quantum RTLS™ include:
- Millimeter-level accuracy
- Real-time 3D tracking
- Operational visibility from a globally accessible platform
- Unprecedented analytics and digitization of physical processes
- Wide-area multi-floor/multi-room/multi-building scalability
- Rapid deployments with patented self-calibration technology
- Easy integration of third-party platforms through open API
Quantum RTLS™ will be available on June 30, 2022. For more information, visit https://www.zerokey.com/products/quantum-rtls .
About ZeroKey: ZeroKey’s patented technology, Quantum RTLS™, is the world’s only wide-area, 3D, millimeter-level RTLS technology that closes the IIoT utility gap in factories, warehouses, and industrial environments worldwide, including with six of the largest ten major automotive OEMs. Powered by ultrasonics, Quantum RTLS™ delivers high performance and reliability at any scale with unparalleled simplicity and flexibility. With a range of trackable tags suitable for diverse applications, ZeroKey technology tracks the assets, processes, goods, and personnel critical to modern business with unprecedented resolution. For more information, visit www.zerokey.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220601005976/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity30.1.2026 07:00:00 CET | Press release
Results from a global survey of over 4,300 women across five continents presented at IMCAS 2026 reveal a knowledge gap on the impact of menopause on the skin, despite women experiencing around three skin changes during menopause1 Galderma will also host a symposium delving into the challenges and science behind menopause-related skin changes and aesthetic solutions at the congress Galderma is committed to raising awareness of the impact of menopause on the skin, fostering meaningful dialogue between patients and healthcare professionals, and advancing science-backed solutions by incorporating menopausal status into all injectable aesthetics clinical trials Galderma (SIX: GALD) has unveiled findings from a global survey of peri- and post-menopausal women from nine countries exploring the impact of menopause on the skin at the International Master Course on Aging Science (IMCAS) 2026 World Congress in Paris, France, from January 29-31, 2026. The survey found that over 50% of women learne
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom